Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
10/31/14 Veloxis Pharma (VELO:DC) Envarsus XR for Kidney Transplant Rejection Subscribers Only Subscribers Only Subscribers Only
10/30/14 Daiichi Sankyo (DSKYF) Savaysa for Stroke Prevention in Atrial Fibrillation (SPAF) Subscribers Only Subscribers Only Subscribers Only
10/30/14 Sarepta (SRPT) Eteplirsen for Muscular Dystrophy Subscribers Only Subscribers Only Subscribers Only
10/30/14 Bristol-Myers Squibb (BMY) Opdivo for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
10/30/14 Neurocrine (NBIX) NBI-98854 for Tardive Dyskinesia Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
11/01/14 Subscribers Only Subscribers Only Trial Data - Updated Results
11/03/14 Subscribers Only Subscribers Only Company - Earnings Announcement
11/03/14 Subscribers Only Subscribers Only Company - Earnings Announcement
11/03/14 Subscribers Only Subscribers Only Company - Earnings Announcement
11/03/14 Subscribers Only Subscribers Only Company - Earnings Announcement